Cargando…

Homologous and Heterologous Prime-Boost Vaccination: Impact on Clinical Severity of SARS-CoV-2 Omicron Infection among Hospitalized COVID-19 Patients in Belgium

We investigated effectiveness of (1) mRNA booster vaccination versus primary vaccination only and (2) heterologous (viral vector–mRNA) versus homologous (mRNA–mRNA) prime-boost vaccination against severe outcomes of BA.1, BA.2, BA.4 or BA.5 Omicron infection (confirmed by whole genome sequencing) am...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meurisse, Marjan, Catteau, Lucy, van Loenhout, Joris A. F., Braeye, Toon, De Mot, Laurane, Serrien, Ben, Blot, Koen, Cauët, Emilie, Van Oyen, Herman, Cuypers, Lize, Robert, Annie, Van Goethem, Nina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961733/ https://www.ncbi.nlm.nih.gov/pubmed/36851257 http://dx.doi.org/10.3390/vaccines11020378

Ejemplares similares

Clinical Severity of SARS-CoV-2 Omicron Variant Compared with Delta among Hospitalized COVID-19 Patients in Belgium during Autumn and Winter Season 2021–2022
por: Van Goethem, Nina, et al.
Publicado: (2022)

Severity of infection with the SARS-CoV-2 B.1.1.7 lineage among hospitalized COVID-19 patients in Belgium
por: Van Goethem, Nina, et al.
Publicado: (2022)

Evaluating methodological approaches to assess the severity of infection with SARS-CoV-2 variants: scoping review and applications on Belgian COVID-19 data
por: Meurisse, Marjan, et al.
Publicado: (2022)

Conceptual causal framework to assess the effect of SARS-CoV-2 variants on COVID-19 disease severity among hospitalized patients
por: Van Goethem, Nina, et al.
Publicado: (2021)

Association between COVID-19 Primary Vaccination and Severe Disease Caused by SARS-CoV-2 Delta Variant among Hospitalized Patients: A Belgian Retrospective Cohort Study
por: Robalo, Queeny, et al.
Publicado: (2022)

Incidence and Risk Factors of COVID-19 Vaccine Breakthrough Infections: A Prospective Cohort Study in Belgium
por: Stouten, Veerle, et al.
Publicado: (2022)

COVID-19 vaccine effectiveness against symptomatic infection and hospitalisation in Belgium, July 2021 to May 2022
por: Braeye, Toon, et al.
Publicado: (2023)

Un cadre conceptuel pour étudier la relation de causalité entre des variants du SARS-CoV-2 et la sévérité de la COVID-19 chez les patients hospitalisés
por: Van Goethem, N., et al.
Publicado: (2022)

Vaccine effectiveness against transmission of alpha, delta and omicron SARS-COV-2-infection, Belgian contact tracing, 2021–2022
por: Braeye, Toon, et al.
Publicado: (2023)

Prioritisation for future surveillance, prevention and control of 98 communicable diseases in Belgium: a 2018 multi-criteria decision analysis study
por: Klamer, Sofieke, et al.
Publicado: (2021)

COVID-19 vaccination uptake in Belgium: socioeconomic and sociodemographic disparities
por: Cavillot, L, et al.
Publicado: (2022)

The role of organizational characteristics on the outcome of COVID-19 patients admitted to the ICU in Belgium
por: Taccone, Fabio Silvio, et al.
Publicado: (2020)

Sévérité de l'infection par le variant Delta du SARS-CoV-2 chez les patients hospitalisés en Belgique
por: Meurisse, M., et al.
Publicado: (2022)

Serial Intervals for SARS-CoV-2 Omicron and Delta Variants, Belgium, November 19–December 31, 2021
por: Kremer, Cécile, et al.
Publicado: (2022)

Factors underlying COVID-19 booster vaccine uptake among adults in Belgium
por: Vermeiren, Elias, et al.
Publicado: (2023)

Organizational characteristics: Effect on outcome of ICU COVID-19 patients in Belgium – Authors' reply
por: TACCONE, Fabio Silvio, et al.
Publicado: (2021)

Vaccine effectiveness against onward transmission of SARS-CoV2-infection by variant of concern and time since vaccination, Belgian contact tracing, 2021
por: Braeye, Toon, et al.
Publicado: (2022)

All-cause mortality supports the COVID-19 mortality in Belgium and comparison with major fatal events of the last century
por: Bustos Sierra, Natalia, et al.
Publicado: (2020)

The association between area deprivation and COVID-19 incidence: a municipality-level spatio-temporal study in Belgium, 2020–2021
por: Meurisse, Marjan, et al.
Publicado: (2022)

Correction to: The association between area deprivation and COVID-19 incidence: a municipality-level spatio-temporal study in Belgium, 2020–2021
por: Meurisse, Marjan, et al.
Publicado: (2022)

Investigating COVID-19 Vaccine Impact on the Risk of Hospitalisation through the Analysis of National Surveillance Data Collected in Belgium
por: Erazo, Diana, et al.
Publicado: (2022)

Stakeholders’ Perception on National Heatwave Plans and Their Local Implementation in Belgium and The Netherlands
por: van Loenhout, Joris Adriaan Frank, et al.
Publicado: (2016)

One year of laboratory-based COVID-19 surveillance system in Belgium: main indicators and performance of the laboratories (March 2020–21)
por: Meurisse, Marjan, et al.
Publicado: (2021)

COVID-19 measures in Belgium: how perception and adherence of the general population differ between time periods
por: van Loenhout, Joris Adriaan Frank, et al.
Publicado: (2022)

Obstacles in measles elimination: an in-depth description of a measles outbreak in Ghent, Belgium, spring 2011
por: Braeye, Toon, et al.
Publicado: (2013)

The Relation between Perceived and Actual Understanding and Adherence: Results from a National Survey on COVID-19 Measures in Belgium
por: Vanderplanken, Kirsten, et al.
Publicado: (2021)

Activity limitations predict health care expenditures in the general population in Belgium
por: Van der Heyden, Johan, et al.
Publicado: (2015)

Infant Pneumococcal Carriage in Belgium Not Affected by COVID-19 Containment Measures
por: Willen, Laura, et al.
Publicado: (2022)

COVID-19 contact tracing in Belgium: main indicators and performance, January – September 2021
por: Proesmans, Kristiaan, et al.
Publicado: (2022)

Characterization of Emerging Serotype 19A Pneumococcal Strains in Invasive Disease and Carriage, Belgium
por: Desmet, Stefanie, et al.
Publicado: (2022)

Comparing the incidence of SARS-CoV-2 across age groups considering sampling biases - use of testing data of autumn 2021 in Belgium
por: Lajot, Adrien, et al.
Publicado: (2023)

A large community outbreak of gastroenteritis associated with consumption of drinking water contaminated by river water, Belgium, 2010
por: BRAEYE, T., et al.
Publicado: (2015)

Investigating the drivers of the spatio-temporal heterogeneity in COVID-19 hospital incidence—Belgium as a study case
por: Dellicour, Simon, et al.
Publicado: (2021)

Childhood leukaemia near nuclear sites in Belgium, 2002–2008
por: Bollaerts, Kaatje, et al.
Publicado: (2018)

Perceived utility and feasibility of pathogen genomics for public health practice: a survey among public health professionals working in the field of infectious diseases, Belgium, 2019
por: Van Goethem, N., et al.
Publicado: (2020)

Socioeconomic characteristics and COVID-19 infection in Belgium: the mediating role of vaccination
por: Ghattas, J, et al.
Publicado: (2023)

If at first you don't succeed, try, try, try again. A message for Public Health Research in Belgium
por: Van Oyen, H
Publicado: (2009)

Opportunities for a population-based cohort in Belgium
por: Schutte, Nienke, et al.
Publicado: (2022)

Vaccine effectiveness against infection and onwards transmission of COVID-19: Analysis of Belgian contact tracing data, January-June 2021
por: Braeye, Toon, et al.
Publicado: (2021)

Epidemiology of hospital-acquired bloodstream infections in Belgium: a retrospective dynamic cohort study, 2000-2014
por: Blot, Koen, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_gi028v12a0o1demhvgqps7s1a8